STAT+: Federal judge rules in favor of hospital lobby in privacy lawsuit
A federal judge has sided with a powerful hospital lobby in a legal battle with…
Category: Medicine
STAT+: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more
And so, another working week will soon draw to a close. Not a moment too…
Can JAK inhibitors bolster checkpoint inhibitors?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Supreme Court outlawed segregation of disabled people 25 years ago. But change has come slowly
As a toddler, Veronica Ayala loved Fridays. At 5 o’clock sharp, her mom whisked her…
Opinion: ‘Patients like mine’ technologies must rest on solid evidence
Vendors of electronic health records and other health technology platforms have begun to publicize and…
Opinion: Medical experts must step up if health justice is to enter the courtroom
Danyel Smith has served 21 years of a life sentence at Dooly Correctional Facility in…
STAT+: Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy
For a third time, Sarepta Therapeutics has convinced a top Food and Drug Administration official…
STAT+: Ginkgo Bioworks lays off 158 employees, with more to come
BOSTON — Ginkgo Bioworks, the once-high-flying Boston life sciences firm, on Thursday said it has…
Screen early in pregnancy for gestational diabetes, new Lancet series urges
Gestational diabetes affects one in seven expecting women globally and rates of this troubling condition…
STAT+: FDA approves Sarepta’s Duchenne gene therapy for nearly all patients
The Food and Drug Administration on Thursday approved Elevidys, Sarepta’s gene therapy for Duchenne muscular…
Change Healthcare to begin notifying patients that cyberattack compromised their private info
Change Healthcare is beginning the process of notifying a “substantial proportion” of Americans that their…
STAT+: Vertex reaches a new deal with NHS England over its pricey cystic fibrosis treatments
After months of haggling, Vertex Pharmaceuticals and the National Health Service in England reached agreement…
Listen: Fauci’s memoir, Alnylam’s tenuous trial, and a mid-year review
Can Alnylam find success with its latest cardiac treatment after tweaking the trial? And did…
STAT+: New immunotherapy combination could ‘change the landscape’ of cancer treatment
When they work, immunotherapy drugs called checkpoint inhibitors can shrink cancers and, in some cases,…
Coalition wages campaign for retractions of Richard Lynn’s racist journal articles
A coalition of researchers, historians, and journalists is urging that major scientific publishers, including Elsevier…
STAT+: Zealand’s amylin-targeting drug shows early potential in obesity
Zealand Pharma on Thursday reported early positive results of an investigational obesity drug that activates…
STAT+: Doctors Without Borders is closing its widely regarded access-to-medicines campaign
In a surprise move, Doctors Without Borders is closing down its access-to-medicines campaign, which has…
STAT+: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more
Rise and shine, everyone, another hot day is on the way. The forecast – at…
STAT+: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected…
Lilly takes more actions against unapproved versions of Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Opinion: Getting ahead of a non-alcoholic beverage boom among youths
The non-alcoholic beverage market is booming right now: zero-proof bottle shops and bars are popping…
STAT+: Bold’s CEO on fall prevention, ageism in health care, and ‘movement is medicine’
BEVERLY HILLS, Calif. – When Amanda Rees was in her twenties she moved in with…
Opinion: Journals that published Richard Lynn’s racist ‘research’ articles should retract them
In 2012, the Elsevier journal Personality and Individual Differences published a special issue that included…
STAT+: New study bolsters evidence rare genetic mutation can delay early Alzheimer’s
For members of a large extended Colombian family, an early Alzheimer’s diagnosis is practically a…
STAT+: Novant Health calls off North Carolina hospital deal, giving a win to the FTC
Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a…
How a Baltimore neuroscience study is rewriting Black America’s relationship with medical research
Priscilla Agnew-Hines will never be able to forget that day in early 2020. On March…
Substance use experts are sounding the alarm on another addiction: gambling
LAS VEGAS — Downstairs was a sensory overload: Roulette wheels spun, slot-machine chimes rang, and…
Opinion: Listen: Why Long Covid can feel scarier than a gun to the head
Millions of people around the world are living with long Covid, a medically perplexing, and…
Opinion: It’s been 60 years since Freedom Summer, yet the fight for affordable, compassionate, and equitable health care is still going on
Sixty years ago this month, a courageous initiative created by civil rights activists and physicians…
STAT+: Republican lawmakers criticize FDA’s partnership with CHAI on regulating AI in medicine
Republican lawmakers are sharply criticizing the Food and Drug Administration’s relationship with a nonprofit group…
There’s a heat wave coming. Here’s what you need to know
Extreme heat is coming this week in many parts of the United States. The Midwest…
On the road to eliminate rabies, Gavi announces plan to improve human vaccination
Rabies has been in global health’s crosshairs for years. Around the world, the viral infection…
STAT+: Boston Scientific to buy vascular device maker for $1.16 billion
Boston Scientific said on Tuesday it will buy Silk Road Medical, a medical device company…
A new era for NIH
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: With the threat of H5N1 bird flu, hospitals must stay prepared
A third case of mammal-to-human transmission of the highly pathogenic H5N1 bird flu virus has…
To treat obesity in children, task force favors behavioral therapy over drugs like Wegovy
A national advisory organization has come down on the side of behavioral interventions, not obesity…
STAT+: Pharmalittle: We’re reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease
A 10-person startup called Marea said Tuesday that it had raised $190 million to help…
Opinion: Why the FDA will have a hard time properly regulating cannabis
The Food and Drug Administration has done a generally exemplary job of executing its mandate…
STAT+: Freespira bets on slow and steady, amid spectacular digital health collapses
Many digital health companies have crashed and burned after promising investors speedy adoption and huge…
With sweeping NIH reform on the table, GOP previews new era of research scrutiny
WASHINGTON — There seems to be broad agreement that change is coming for the National…
Opinion: Long Covid feels like a gun to my head
I have spent my career studying infectious diseases that fall under the heading of neglected…
STAT+: To feed an AI that designs new enzymes, Basecamp hunts rare proteins at the world’s end
Not many AI companies have expeditions to the rainforest on the calendar, or need scientists…
This federal rule didn’t stop coercive sterilization — but it blocked contraceptive access. Can it be fixed?
Sonya Borrero didn’t learn about forced sterilization in medical school. She learned about it from…
What’s the evidence for the Surgeon General’s proposed social media warning?
United States Surgeon General Vivek Murthy wants to add a warning label on social media….
STAT+: Former medical device CEO who sold fake plastic parts sentenced to 6 years in prison
The former CEO of Stimwave, a company that sold pain-relief devices with dummy pieces of…
New Merck pneumococcal vaccine wins FDA approval
The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18…
STAT+: Why health care spending keeps climbing
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…